Conexeu Sciences Inc.
CNXUNasdaqCIK 2066836HealthcareFiscal year ends Oct 31
Income statement
| Line item | Unit | period not labelled2025-04-30 | period not labelled2025-07-31 | Q2 FY20262026-04-30 | Q3 FY20262026-07-31 |
|---|---|---|---|---|---|
| Research and development | $k | 42.5Research and development, period not labelled, three months to 2025-04-30$42.5k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 135Research and development, period not labelled, three months to 2025-07-31$134.7k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 66.6Research and development, Q2 FY2026, three months to 2026-04-30$66.6k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 270Research and development, Q3 FY2026, three months to 2026-07-31$270.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Operating income | $k | (457)Operating income, period not labelled, three months to 2025-04-30−$457.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (1,298)Operating income, period not labelled, three months to 2025-07-31−$1.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | (2,380)Operating income, Q2 FY2026, three months to 2026-04-30−$2.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (7,688)Operating income, Q3 FY2026, three months to 2026-07-31−$7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Interest expense | $k | 1.4Interest expense, period not labelled, three months to 2025-04-30$1.4k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (0.0)Interest expense, period not labelled, three months to 2025-07-31−$43. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 0.0Interest expense, Q2 FY2026, three months to 2026-04-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 0.0Interest expense, Q3 FY2026, three months to 2026-07-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Income tax | $k | 0.0Income tax, period not labelled, three months to 2025-04-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 0.0Income tax, period not labelled, three months to 2025-07-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 0.0Income tax, Q2 FY2026, three months to 2026-04-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 0.0Income tax, Q3 FY2026, three months to 2026-07-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Net income | $k | (458)Net income, period not labelled, three months to 2025-04-30−$458.1k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (1,299)Net income, period not labelled, three months to 2025-07-31−$1.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | (2,304)Net income, Q2 FY2026, three months to 2026-04-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (7,726)Net income, Q3 FY2026, three months to 2026-07-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Diluted EPS | $ per share | (0.05)Diluted EPS, period not labelled, three months to 2025-04-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (0.09)Diluted EPS, period not labelled, three months to 2025-07-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | (0.11)Diluted EPS, Q2 FY2026, three months to 2026-04-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (0.29)Diluted EPS, Q3 FY2026, three months to 2026-07-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Basic EPS | $ per share | (0.05)Basic EPS, period not labelled, three months to 2025-04-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (0.09)Basic EPS, period not labelled, three months to 2025-07-31−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | (0.11)Basic EPS, Q2 FY2026, three months to 2026-04-30−$0.11 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | (0.29)Basic EPS, Q3 FY2026, three months to 2026-07-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
Balance sheet
| Line item | Unit | period not labelled2024-10-31 | period not labelled2025-02-01 | period not labelled2025-04-30 | period not labelled2025-07-31 | period not labelled2025-10-31 | period not labelled2026-01-31 | Q2 FY20262026-04-30 | Q3 FY20262026-07-31 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $k | not reported | not reported | not reported | not reported | 4,809Cash and equivalents, period not labelled, at 2025-10-31$4.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | not reported | 6,848Cash and equivalents, Q2 FY2026, at 2026-04-30$6.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 1,971Cash and equivalents, Q3 FY2026, at 2026-07-31$2.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Current assets | $k | not reported | not reported | not reported | not reported | 7,458Current assets, period not labelled, at 2025-10-31$7.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | not reported | 7,914Current assets, Q2 FY2026, at 2026-04-30$7.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 6,756Current assets, Q3 FY2026, at 2026-07-31$6.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Total assets | $k | not reported | not reported | not reported | not reported | 7,689Total assets, period not labelled, at 2025-10-31$7.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | not reported | 8,200Total assets, Q2 FY2026, at 2026-04-30$8.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 7,156Total assets, Q3 FY2026, at 2026-07-31$7.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Current liabilities | $k | not reported | not reported | not reported | not reported | 336Current liabilities, period not labelled, at 2025-10-31$336.0k. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | not reported | not reported | 1,272Current liabilities, Q3 FY2026, at 2026-07-31$1.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Total liabilities | $k | not reported | not reported | not reported | not reported | 336Total liabilities, period not labelled, at 2025-10-31$336.0k. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | not reported | 1,003Total liabilities, Q2 FY2026, at 2026-04-30$1.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 1,306Total liabilities, Q3 FY2026, at 2026-07-31$1.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
| Shareholders' equity | $k | 95.0Shareholders' equity, period not labelled, at 2024-10-31$95.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 570Shareholders' equity, period not labelled, at 2025-02-01$570.5k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 177Shareholders' equity, period not labelled, at 2025-04-30$176.7k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 1,655Shareholders' equity, period not labelled, at 2025-07-31$1.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 7,353Shareholders' equity, period not labelled, at 2025-10-31$7.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 6,826Shareholders' equity, period not labelled, at 2026-01-31$6.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-06-15, accession 0001062993-26-003207.Report this figure | 7,196Shareholders' equity, Q2 FY2026, at 2026-04-30$7.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure | 5,850Shareholders' equity, Q3 FY2026, at 2026-07-31$5.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-09-14, accession 0001062993-26-004935.Report this figure |
Cash flow
| Line item | Unit | period not labelled2025-07-31 | Q3 FY20262026-07-31 |
|---|---|---|---|
| Operating cash flow | $k | (574)Operating cash flow, period not labelled, three months to 2025-07-31−$573.8k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-14, accession 0001062993-26-004935. Derived: 9-month figure less the 6-month figure.Report this figure | (6,759)Operating cash flow, Q3 FY2026, three months to 2026-07-31−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-14, accession 0001062993-26-004935. Derived: 9-month figure less the 6-month figure.Report this figure |
| Capital expenditure | $k | 0.4Capital expenditure, period not labelled, three months to 2025-07-31$400. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-14, accession 0001062993-26-004935. Derived: 9-month figure less the 6-month figure.Report this figure | 41.4Capital expenditure, Q3 FY2026, three months to 2026-07-31$41.4k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-14, accession 0001062993-26-004935. Derived: 9-month figure less the 6-month figure.Report this figure |
Shares
| Line item | Unit | period not labelled2025-04-30 | period not labelled2025-07-31 | Q2 FY20262026-04-30 | Q3 FY20262026-07-31 |
|---|---|---|---|---|---|
| Diluted shares (weighted) | m shares | 9.5 | 14.1 | 20.6 | 27.0 |
Shares outstanding: 28.21m at Sep 10, 2026, from the cover of the 10-Q filed Sep 14, 2026.
Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.